Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066943
Filing Date
2025-05-08
Accepted
2025-05-08 16:10:02
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sana-20250331.htm   iXBRL 10-Q 2718911
2 EX-10.1 sana-ex10_1.htm EX-10.1 31516
3 EX-31.1 sana-ex31_1.htm EX-31.1 18066
4 EX-32.1 sana-ex32_1.htm EX-32.1 9828
5 GRAPHIC img113600494_0.jpg GRAPHIC 94388
  Complete submission text file 0000950170-25-066943.txt   10389734

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sana-20250331.xsd EX-101.SCH 1379411
84 EXTRACTED XBRL INSTANCE DOCUMENT sana-20250331_htm.xml XML 1780614
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39941 | Film No.: 25926121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)